NCT03896139View on ClinicalTrials.gov

Identification of PAthways of Kinase Inhibitors TOxicity

CompletedOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Kinase Inhibitors Toxicity
Interventions
DRUG

Kinase inhibitor

Patients treated with kinase inhibitors for cancer or other conditions

Trial Locations (1)

Unknown

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03896139 - Identification of PAthways of Kinase Inhibitors TOxicity | Biotech Hunter | Biotech Hunter